WednesdayNov 01, 2023 9:45 am

Insights and Opportunities Unfold as the 2023 New Orleans Investment Conference Kicks Off

Serious investors — and anyone concerned with protecting and building wealth in volatile times — invited to attend the New Orleans Investment Conference to be held in New Orleans, November 1-4, 2023. With a rich legacy spanning almost 50 years, the New Orleans Investment Conference has been acclaimed as “The Greatest Investment Show on Earth” by Money Magazine. Held in the heart of New Orleans, the 2023 Conference is set to present a dream team of world-class experts on geopolitics, macroeconomics and every asset class to hundreds of savvy investors. The 2023 Conference will feature enlightening presentations from leading experts…

Continue Reading

WednesdayNov 01, 2023 9:00 am

SuperCom Ltd. (NASDAQ: SPCB) Eyes the Growing World Market for Domestic Violence Offender Monitoring Solutions

The UK’s criminal justice department recently announced that domestic abusers leaving prison will be wearing electronic monitoring tags for better victim protection Up to 500 offenders will be forced to wear GPS and curfew tags to monitor their movements, with those who breach the stipulated license conditions being returned to prison This move by the UK validates digital monitoring solutions such as SuperCom’s Electronic Monitoring (“EM”) products It also shows the technology’s viability in solving emerging issues while also validating SuperCom’s research and development efforts as targeting an active and growing world market SuperCom (NASDAQ: SPCB), a global provider of…

Continue Reading

TuesdayOct 31, 2023 12:00 pm

Exploring the Future of Finance at the New Orleans Investment Conference 2023

Investors, policymakers, enthusiasts, technologists, decision-makers, and business owners are invited to attend the New Orleans Investment Conference to be held in New Orleans, Louisiana, November 1-4, 2023. The 2023 edition of this iconic event is committed to paving the way to real investment insights and financial wisdom in a fast-changing economic landscape. Having a rich history of successful investment symposiums, the New Orleans Investment Conference has consistently brought together some of the brightest minds in finance, politics, and economics. The conference will feature a lineup of world-renowned speakers who will share valuable investment strategies to unlock the secrets of financial…

Continue Reading

TuesdayOct 31, 2023 10:30 am

Freight Technologies Inc. (NASDAQ: FRGT) Taking Part in the Trucking Industry’s Ongoing Paradigm Shift with Its Fr8App Platform

Lexaria, a global innovator in drug delivery platforms, just announced an exclusive license to SulfoSyn Limited to use its patented DehydraTECH(TM) technology Lexaria will also perform specific DehydraTECH-related manufacturing operations on SulfoSyn’s behalf for an initial term of 2 years The license agreement adds to Lexaria’s growing list, which, as of the last two years, includes BevNology LLC, Premier Wellness Science Co. Ltd., and Dehydr8, LLC, among others It highlights the superiority of Lexaria’s technology, as further compounded by the 37 patents granted so far Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its latest…

Continue Reading

TuesdayOct 31, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Grows List of Licensed Partners Following Exclusive Collaboration and License Agreement with SulfoSyn

Lexaria, a global innovator in drug delivery platforms, just announced an exclusive license to SulfoSyn Limited to use its patented DehydraTECH(TM) technology Lexaria will also perform specific DehydraTECH-related manufacturing operations on SulfoSyn’s behalf for an initial term of 2 years The license agreement adds to Lexaria’s growing list, which, as of the last two years, includes BevNology LLC, Premier Wellness Science Co. Ltd., and Dehydr8, LLC, among others It highlights the superiority of Lexaria’s technology, as further compounded by the 37 patents granted so far Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its latest…

Continue Reading

MondayOct 30, 2023 3:00 pm

Diamond Lake Minerals Inc. (DLMI) Welcomes Brian J. Esposito As Company CEO In Addition To Seven New Strategic Advisors

Brian J. Esposito, founder and CEO of Esposito Intellectual Enterprises, LLC., boasts 20 years of experience and a proven track record of driving growth and innovation Increase in Strong Advisory Board: Agnes Budzyn, Anthony Scaramucci, Larry Namer, Michael J. Malik Sr., Andrew Fromm, Brandon Fugal, and Raul Leal Newest board additions bring the company closer to its ultimate vision and further strengthen its competitive advantages, including innovative technology, a diverse portfolio, and highly experienced leadership Diamond Lake Minerals (OTC: DLMI), a company positioning itself as a rapidly developing leader in the digital asset and security token space, recently announced the…

Continue Reading

MondayOct 30, 2023 2:30 pm

Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0) Eyes Growth on New Pricing for SekurVPN Packages, Launch of Communication Suite in German Language

Sekur Private Data has reported increasing new subscriber signups for SekurVPN, the world’s first non-big-tech-powered, Swiss-hosted privacy-focused VPN solution launched in April So far, SekurVPN’s sales have surpassed its projections, and the company is now expecting solid growth for SekurVPN for the foreseeable future The company recently announced plans to increase its prices for SekurVPN by 30%, following careful considerations and consultations with the digital marketing team Even with the new prices, SekurVPN is still the most affordable privacy VPN in the market, according to CEO Alain Ghiai Sekur Private Data recently announced plans to launch its Swiss-hosted communications suite,…

Continue Reading

MondayOct 30, 2023 11:15 am

Mountain Top Properties Inc. (MTPP) Is ‘One to Watch’

Mountain Top Properties has issued 250,108,363 shares of common stock as of August 2023 The company will consider selling securities to fund future operations Mountain Top Capital Fund I has a target to raise $75 million to fund its Hamptons projects The company targets minimum ROI of 20% to 30% per transaction Mountain Top Properties (OTC: MTPP) is a diversified real estate holding company that acquires, sells and operates assets through its wholly owned subsidiaries and limited partnerships. The company specializes in property management, property technology (“PropTech”) and real estate redevelopment. Mountain Top Properties was incorporated in 1990 and is…

Continue Reading

MondayOct 30, 2023 10:30 am

SenesTech Inc. (NASDAQ: SNES) Geometrically Increases its Addressable Market with the Addition of Evolve(TM) Soft Bait to its Portfolio

SenesTech, a rodent fertility control expert, just announced the launch of its Evolve(TM) Soft Bait, representing an innovative, patent pending, minimum risk alternative treatment to reduce fertility in rats This product adds to the company’s growing line of pest control solutions, such as ContraPest(R), a highly palatable liquid contraceptive bait SenesTech’s management has lauded this milestone, noting how the product, with its non-liquid form, will dramatically increase its addressable market The company plans to market it to professionals as well as directly to consumers through e-commerce and big-box stores SenesTech (NASDAQ: SNES), a rodent fertility control expert and the inventor…

Continue Reading

MondayOct 30, 2023 9:45 am

Clene Inc. (NASDAQ: CLNN) Reports Improved Survival Status in ALS Patients Treated with CNM-Au8(R) on Follow-Up Analysis; Announces Peer-Reviewed Study

Clene is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases like ALS In 2019, Clene’s drug candidate, CNM-Au8(R), was selected for the HEALEY ALS Platform Trial, with enrollment commencing in the summer of 2020 Over the years since, Clene has consistently released additional data from the Trial, most recently reporting significant long-term survival improvement among patients treated with CNM-Au8 compared to PRO-ACT historical controls The company also announced the publication of a peer-reviewed study in the nanotechnology-focused journal Small; the study describes CNM-Au8’s mechanism of action Clene received a $45.1…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered